The European Medicines Agency (EMA) launched a micro-, small- and medium-sized-enterprise (SME) office in 2005. The office is dedicated to addressing the particular needs of smaller companies.
The establishment of the SME office followed the European Commission's adoption of specific provisions on 15 December 2005. These provisions were aimed at promoting innovation and the development of new medicines for human and veterinary use by SMEs.
For information on the assistance that the SME office offers to SMEs, see:
How useful is this page?
Average rating:Based on 43 ratings
Add your rating:
- See all ratings
19 ratings0 ratings2 ratings6 ratings16 ratings
Related EU legislation
Tel. +44 (0)20 3660 8787